171 Preclinical studies support therapeutic application of the leukemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer

• Satwinder Kaur Singh,
• Maho Nagasawa,
• Remco Bos,
• Haoxiao Zuo,
• Kiave Yune Ho Wang Yin,
• Marie-José van Lierop,
• Sebastien Tabruyn,
• Erik Manting,
• Marco de Bruyn,
• Hans Nijman

Affiliations

Satwinder Kaur Singh

1DCprime, Leiden, Netherlands

Maho Nagasawa

1DCprime, Leiden, Netherlands

Remco Bos

1DCprime, Leiden, Netherlands

Haoxiao Zuo

1DCprime, Leiden, Netherlands

Kiave Yune Ho Wang Yin

2TransCure BioServices, Archamps, France

Marie-José van Lierop

1DCprime, Leiden, Netherlands

Sebastien Tabruyn

2TransCure BioServices, Archamps, France

Erik Manting

1DCprime, Leiden, Netherlands

Marco de Bruyn

3University Medical Center Groningen, Groningen, Netherlands

Hans Nijman

3University Medical Center Groningen, Groningen, Netherlands